Prague, Czechia

Dagmar Hulinska

This inventor holds 1 USPTO granted patent. Top assignee: Ceskoslovenska Akademie Ved. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dagmar Hulinska. Retrieved from https://idiyas.com/inventor/dagmar-hulinska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dagmar Hulinska: Innovator in Muscle Regeneration

Introduction

Dagmar Hulinska is a notable inventor based in Prague, Czech Republic. She has made significant contributions to the field of muscle regeneration through her innovative research and inventions. Her work focuses on improving the regenerative processes of injured striated muscles, which is crucial for recovery in various medical conditions.

Latest Patents

Dagmar holds a patent for the "Preparation of the improvement of the regenerative process of injured." This invention relates to a treatment aimed at enhancing the regeneration of injured striated muscles. The key feature of her invention is the application of n-butylamine, either in its natural or ionic form, or in a buffered solution, as an effective substance for muscle recovery. She has 1 patent to her name.

Career Highlights

Dagmar is affiliated with the Czech Academy of Sciences, where she conducts her research and develops her inventions. Her work has garnered attention for its potential impact on medical treatments and rehabilitation processes.

Collaborations

Dagmar has collaborated with notable colleagues, including Jan Zenka and Radim Holusa, who have contributed to her research endeavors.

Conclusion

Dagmar Hulinska's innovative work in muscle regeneration showcases her dedication to advancing medical science. Her contributions are paving the way for improved treatments in muscle recovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…